Legal Representation
Attorney
Peter M. Klobuchar
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 6, 2014 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Mar 5, 2014 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Aug 7, 2013 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 7, 2013 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Aug 7, 2013 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jul 16, 2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 15, 2013 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 15, 2013 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 15, 2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 15, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 15, 2013 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 15, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 14, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 20, 2012 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Sep 20, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely: prescription and non-prescription drugs for the treatment of: musculoskeletal disorders, epilepsy, emphysema, breast cancer, infection, cardiac arrhythmia, hypertension, pain, allergies, eye infections, mastocytosis, cysts, arthritis, spondylitis, throat irritation, bronchial irritation, cough and nasal congestion, bacterial conjunctivitis, high blood pressure, conjunctivitis, corneal ulcers, inflammation, convulsions, seizures, eye pressure, Parkinson's Disease, tremors, ear infections, bipolar disorder, overactive bladder, asthma, diabetes, depression, migraines, potassium deficiency, vertigo, menopausal conditions and symptoms, edema, hypotension, actinic keratosis, endometriosis, dry mouth, Vitamin D deficiency, altitude and motion sickness, coagulation disorders, Crohn's Disease; anti viral, anti fungal and anti psychotic medications; and potassium supplements
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005